UMR CNRS 5558 Laboratoire de Biométrie et Biologie Évolutive

Castellan AC, Tod M, Gueyffier F, Audars M, Cambriels F, Kassai B, Nony P (2013)
Quantitative Prediction of the Impact of Drug Interactions and Genetic Polymorphisms on Cytochrome P450 2C9 Substrate Exposure, Clin Pharmacokinet, vol. 52 pp.199-209, DOI.

Dumont T, Duarte M, Descombes S, Dronne MA, Massot M, Louvet V (2013)
Simulation of human ischemic stroke in realistic 3D geometry, Communications in Nonlinear Science and Numerical Simulation, vol. 18 pp.1539-1557, DOI.

Goutelle S, Baudry T, Gagnieu M C, Boibieux A, Livrozet J M, Peyramond D, Chidiac C, Tod M, Ferry T (2013)
Pharmacokinetic-Pharmacodynamic Modeling of Unboosted Atazanavir in a Cohort of Stable HIV-Infected Patients, Antimicrob Agents Chemother, vol. 57 pp.517-523, DOI.

Goutelle S, Bourguignon L, Bleyzac N, Berry J, Clavel-Grabit F, Tod M (2013)
In Vivo Quantitative Prediction of the Effect of Gene Polymorphisms and Drug Interactions on Drug Exposure for CYP2C19 Substrates, The AAPS Journal, vol. 15 pp.415-26, DOI.

Ohmann C, Canham S, Cornu C, Dress J, Gueyffier F, Kuchinke W, Nicolis EB, Wittenberg M (2013)
Revising the ECRIN tandard requirements for information technology and data management in clinical trials, Trials, vol. 14 pp.97-97, DOI.

Bejan-Angoulvant T, Baguet J-P, Erpeldinger S, Boivin J-M, Mercier A, Leftheriotis G, Gagnol J-P, Fauvel J-P, Giraud C, Bricca G, Gueyffier F (2012)
The IDEAL Study : Towards Personalized Drug Treatment of Hypertension, Thérapie, vol. 67 pp.195-204.

Bleyzac N (2012)
On the importance of blood sampling for cyclosporine pharmacokinetic studies, Br J Clin Pharmacol, vol. pp.605-608, DOI.

Boissonnat P, Gaillard S, Mercier C, Redonnet M, Lelong B, Mattei MF, Mouly-Bandini A, Pattier S, Sirinelli A, Epailly E, Varnous S, Billes M A, Sebbag L, Ecochard R, Cornu C, Gueyffier F (2012)
Impact of the early reduction of cyclosporine on renal function in heart transplant patients: a French randomised controlled trial, Trials, vol. 13 pp.231-231, DOI.

Bonnefoy M, Boutitie F, Mercier C, Gueyffier F, Carre C, Guetemme G, Ravis B, Laville M, Cornu C (2012)
EFFICACY OF A HOME-BASED INTERVENTION PROGRAMME ON THE PHYSICAL ACTIVITY LEVEL AND FUNCTIONAL ABILITY OF OLDER PEOPLE USING DOMESTIC SERVICES: A RANDOMISED STUDY, The Journal of Nutrition Health and Aging, vol. 16 pp.370-377.

Boussageon R, Supper I, Bejan-Angoulvant T, Kellou N, Cucherat M, Boissel J-P, Kassai B, Moreau A, Gueyffier F, Cornu C (2012)
Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials, PLoS Med, vol. 9 pp.347-351.

Charhon N, Neely M N, Bourguignon L, Maire P, Jelliffe R W, Goutelle S (2012)
Comparison of Four Renal Function Estimation Equations for Pharmacokinetic Modeling of Gentamicin in Geriatric Patients, ASM Antimicrobial Agents and Chemotherapy, vol. 56 pp.1862-1869.

Commeau N, Parent E, Delignette-Muller M-L, Cornu C (2012)
Fitting a lognormal distribution to enumeration and absence/presence data, International Journal of Food Microbiology, vol. 155 pp.146-152.

Couzan S, Leizorovicz A, Laporte S, Mismetti P, Pouget JF, Chapelle C, Quéré I (2012)
A randomized double-blind trial of upward progressive vs degressive compressive stockings in patients with moderate to severe chronic venous insufficiency, J Thromb Haemost, vol. pp.1-3.

Crowther MJ, Riley RD, Staessen JA, Wang J, Gueyffier F, Lambert PC (2012)
Individual patient data meta-analysis of survival data using Poisson regression models, BMC Medical Research Methodology, vol. 12 pp.34-34, DOI.

De Souza V C, Rabilloud M, Cochat P, Selistre L, Hadj-Aissa A, Kassai B, Ranchin B, Berg U, Herthelius M, Dubourg L (2012)
Schwartz Formula: Is One k-Coefficient Adequate for All Children?, PLoS one, vol. 7 pp.e53439-e53439, DOI.

Désaméricq G, Van Ganse E, Schwalm MS, Bourke A, Moulin P (2012)
Severe hypertriglceridaemia in patients treated with lipid-modifying agents, Diabetes Metab, vol. 38 pp.276-279, DOI.

Diao D, Wright JM, Cundiff DK, Gueyffier F (2012)
Pharmacotherapy for mild hypertension (Review), COCHRANE DATABASE OF SYSTEMATIC REVIEWS, vol. pp.1-28, DOI.

Escuret V, Cornu C, Boutitie F, Ernouf V, Mosnier A, Bouscambert-Duchamp M, Gaillard S, Duval X, Blanchon T, Leport C, Gueyffier F, Van Der Werf S, Lina B (2012)
Oseltamivir–zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) influenza virus infections, Antiviral Research, vol. pp.1-8.

Galanaud JP, Bosson JL, Genty C, Presles E, Cucherat M, Sevestre MA, Quere I, Decousus H, Leizorovicz A (2012)
Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies, J Thromb Haemost, vol. pp.1-23.

Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delphine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Gollier G, Gommeaux A, Claudel J-P, Bourlon F, Bertrand B, Van Belle E, Laskar M, the FRANCE 2 Investigators (2012)
Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients, The New England Journal of Medicine, vol. 366 pp.1705-1715.

Goutelle S, Tod M (2012)
Prédiction quantitative des interactions médicamenteuses impliquant les cytochromes 3A4 et 2D6 : approche in vivo, La lettre du Pharmacologue, vol. 26 pp.57-62.

Janoly-Dumenil A, Rouvet I, Bleyzac N, Morfin F, Zabot MT, Tod M (2012)
A pharmacodynamic model of ganciclovir antiviral effect and toxicity for lymphoblastoid cells suggests a new dosing regimen to treat cytomegalovirus infection, Antimicrob Agents Chemother, vol. 56 pp.3732-8, DOI.

Laforest L, Ambegaonkar BM, Souchet T, Sazonov V, Van Ganse E (2012)
Mixed dyslipidemias in primary care patients in France, Vasc Health Risk Manag, vol. 8 pp.247-254, DOI.

Lenoir-Wijnkoop I, Nuijten M J, Gutierrez-Ibarluzea I, Hutton J, Poley MJ, Segal L, Bresson JL, Van Ganse E, Jones P, Moreno L, Salminen S, Dubois D (2012)
Workshop Report: concepts and methods in the economics of nutrition--gateways to better economic evaluation of nutrition interventions, British Journal of Nutrition, vol. 108 pp.1714-20, DOI.

Leroy B, Uhart M, Maire P, Bourguignon L (2012)
Evaluation of fluoroquinolone reduced dosage regimens in elderly patients by using pharmacokinetic modelling and Monte Carlo simulations, Journal of Antimicrobial Chemotherapy, vol. pp.1-6.

Michallet M, Bénet T, Sobh M, Kraghel S, El Hamri M, Cannas G, Nicolini F-E, Labussière H, Ducastelle S, Barraco F, Thomas X, Chelghoum Y, Nicolle M-C, Bienvenu A-L, Persat F, De Monbrison F, Picot S, Vanhems P (2012)
Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients, European Journal of Clinical Microbiology & Infectious Diseases, vol. 31 pp.991-997, DOI.

Moss R, Grosse T, Marchant I, Lassau N, Gueyffier F, Thomas S R (2012)
Virtual Patients and Sensitivity Analysis of the Guyton Model of Blood Pressure Regulation: Towards Individualized Models of Whole-Body Physiology, PloS Computational Biology, vol. 8 pp.e1002571-e1002571.

Paci A, Vassal G, Moshous D, Dalle JH, Bleyzac N, Neven B, Galambrun C, Kemmel V, Abdi ZD, Broutin S, Pétain A, Nguyen L (2012)
Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older Children: The Results of a Population Pharmacokinetic Study From a Large Pediatric Cohort Undergoing Hematopoietic Stem-Cell Transplantation., Therapeutic Drug Monitoring, vol. 34 pp.198-208, DOI.

Pelissolo A, Zaoui M, Aguayo G, Nan Yao S, Roche S, Ecochard R, Gueyffier F, Pull C, Berthoz A, Jouvent R, Cottraux J (2012)
Virtual reality exposure therapy versus cognitive behavior therapy for panic disorder with agoraphobia: a randomized comparison study, Journal of CyberTherapy & Rehabilitation, vol. 5 pp.35-43.

Pina G, Dubois S, Murat A, Berger N, Niccoli P, Peix J-L, Cohen R, Guillausseau C, Charrie A, Chabre O, Cornu C, Borson-Chazot F, Rohmer V (2012)
Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?, Clinical Endocrinology, vol. pp.1-23.

Quenet S, Laroche J-P, Bertoletti L, Quéré I, Décousus H, Becker F, Leizorovicz A (2012)
Value of a Planned Compression Ultrasonography after an Isolated Superficial Vein Thrombosis: Results from a Prospective Multicentre Study, European Journal of Vascular and Endovascular Surgery, vol. 43 pp.233-237.

Reix P, Aubert F, Werck-Gallois MC, Toutain A, Mazzocchi C, Moreux N, Bellon G, Rabilloud M, Kassai B (2012)
Exercise with incorporated expiratory manoeuvres was as effective as breathing techniques for airway clearance in children with cystic fibrosis: a randomised crossover trial, journal of Physiotherapy, vol. 58 pp.241-247.

Scholtes C, Andre P, Trepo C, Cornu C, Remontet L, Ecochard R, Bejan-Angoulvant T, Gueyffier F (2012)
Farnesoid X Receptor Targeting for Hepatitis C: Study Protocol for a Proof-of-concept Trial, Thérapie, vol. 67 pp.423-427, DOI.

Sonié S, Kassai B, Pirat E, Bain P, Robinson J, Gomot M, Barthélémy C, Charvet D, Rochet T, Tatou M, Assouline B, Cabrol S, Chabane N, Arnaud V, Faure P, Manificat S (2012)
The French Version of the Autism-Spectrum Quotient in Adolescents: A Cross-Cultural Validation Study, J Autism Dev Disord, vol. pp.1-6.

Uhart M, Odouard E, Carlier C, Maire P, Ducher M, Bourguignon L (2012)
Relationship between benzodiazepines use and falls in the elderly: A multicenter study in three geriatric centers of a university hospital, Annales Pharmaceutiques Françaises, vol. 70 pp.46-52.

Van Ganse E, Letrilliart L, Borne H, Morand F, Robain M, Siegrist CA (2012)
Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination program, Pharmacoepidemiol Drug Saf, vol. 21 pp.261-268, DOI.

Berthe A, Duclos A, Ray-coquard I, Colin C, Bleyzac N (2011)
Assessment of adherence to Afssaps guidelines for the prescription of antifungals in pediatric hemato-oncology, Med Mal Infect, vol. 41 pp.25-32, DOI.

Bonnefoy M, Boutitie F, Mercier C, Gueyffier F, Carré C, Guetemme G, Ravis B, Laville M, Cornu C (2011)
EFFICACY OF A HOME-BASED INTERVENTION PROGRAMME ON THE PHYSICAL ACTIVITY LEVEL AND FUNCTIONAL ABILITY OF OLDER PEOPLE USING DOMESTIC SERVICES: A RANDOMISED STUDY, The Journal of Nutrition Health and Aging, vol. pp.1-8.

Bonnefoy-Cudraz E, Kirkorian G (2011)
La mortalité des syndromes coronariens aigus, Annales de Cardiologie et d`Angéiologie, vol. 60 pp.311-316.

Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C (2011)
Effect of intensive glucose lowering treatment on all cause mortality cardiovascular death and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials, British Medical Journal, vol. 343 pp.1-12 .

Bresson D, Sibellas F, Farhat F, Jegaden O, Kirkorian G, Bonnefoy-Cudraz E (2011)
Preliminary experience with Impella Recover® LP5.0 in nine patients with cardiogenic shock: A new circulatory support system in the intensive cardiac care unit, Archives of Cardiovascular Disease, vol. 104 pp.458-464.

Burgos Leon-Dijan C, Bourguignon L, Späth H-M, Maire P (2011)
Étude coût-efficacité de l’adaptation bayésienne des posologies des aminosides en gériatrie, Pharmacoéconomie, vol. 66 pp.445-452.

Cornu C, Nony P (2011)
Women Were Included Twice in a Meta-Analysis, THE AMERICAN JOURNAL of MEDICINE, vol. pp.1-1.

Courand P-Y, Croisille P, Khouatra C, Cottin V, Kirkorian G, Bonnefoy-Cudraz E (2011)
Churg–Strauss Syndrome Presenting with Acute Myocarditis and Cardiogenic Shock, Heart Lung and Circulation, vol. pp.1-4.

De Boeck K, Bulteel V, Tiddens H, Wagner T, Fajac I, Conway S, Dufour F, Smyth AR, Lee T, Serment I, Kassaï B, Elborn S (2011)
Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society–Clinical Trials Network (ECFS-CTN), Journal of Cystic Fibrosis, vol. 10 suppl 2 pp.S67-S74.

Décousus H, Bertoletti L, Frappé P, Becker F, El Jaouhari A, Mismetti P, Moulin N, Presles E, Quéré I, Leizorovicz A (2011)
Recent findings in the epidemiology diagnosis and treatment of superficial-vein thrombosis, Thrombosis Research, vol. 127(3) pp.81-85.

Domenech C, Rabodonirina M, Bleyzac N, Pagès MP, Bertrand Y (2011)
Cryptosporidiosis in Children With Acute Lymphoblastic Leukemia on Maintenance Chemotherapy, Journal of Pediatric Hematology Oncology, vol. 33 pp.570-572, DOI.

Dubourg J, Javouhey E, Geeraerts T, Messerer M, Kassaï B (2011)
Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis, Intensive care medicine, vol. pp.1-10.

Gerard C, Bleyzac N, Girard P, Freyer G, Bertrand Y, Tod M (2011)
Links between cyclosporin exposure in tissues and graft-versus-host disease in pediatric bone marrow transplantation: analysis by a PBPK model, Pharm Res, vol. 28 pp.531-9, DOI.

Gouin-Thibault I, Liard F, Van-Ganse E, Vespa L, Gaudin A F, Nachit-Ouinekh F (2011)
Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study, Presse Med, vol. 40 pp.e365-75, DOI.

Goutelle S, Bourguignon L, Jelliffe R-W, Conte JE, Maire P (2011)
Mathematical modeling of pulmonary tuberculosis therapy: Insights from a prototype model with rifampin, Journal of Theoretical Biology, vol. 282 pp.80-82.

Goutelle S, Mialou V, Gouraud A, Parant F, Bleyzac N (2011)
Probable Drug Interaction Between Intravenous Ciprofloxacin and Mycophenolate Mofetil in a Bone Marrow Transplant Recipient, Pharmacotherapy, vol. 31(1) pp.36-40.

Gueyffier F, Perez MI, Wright JM, Marchant I, Musini VM, Bejan-Angoulvant T (2011)
Blood pressure lowering in the oldest old: a step toward abandoning arbitrary blood pressure targets, Journal of Hypertension, vol. 29 pp.171-175.

Guignant C, Lepage C, Huang X, Kherouf H, Denis L, Poitevin F, Malcus C, Chéron A, Allaouchiche B, Gueyffier F, Ayala A, Monneret G, Venet F (2011)
Programmed death-1 levels correlate with increased mortality nosocomial infection and immune dysfunctions in septic shock patients, BioMed Central, vol. 15(R99) pp.1-11.

Laforest L, Com-Ruelle L, Broquet M, Devouassoux G, Van Ganse E (2011)
Coût de l`asthme en France, La revue du praticien, vol. pp.40-42.

Lecointre R, Bleyzac N (2011)
Invasive fungal infections in oncology and haematology unit care: review of literature and costs analysis, Ann Pharm Fr, vol. 69 pp.214-20, DOI.

Lenoir-Wijnkoop I, Dapoigny M, Dubois D, Van Ganse E, Gutierrez-Ibarluzea I, Hutton J, Jones P, Mittendorf T, Poley M J, Salminen S, Nuijten MJ (2011)
Nutrition economics - characterising the economic and health impact of nutrition, Br J Nutr, vol. 105 pp.157-166, DOI.

Lièvre M, Moulin P, Thivolet C, Rodier M, Rigalleau V, Penfornis A, Pradignac A, Ovize M (2011)
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening, Trials, vol. 12(23) pp.1-7.

Marchant I, Nony P, Cucherat M, Boissel J-P, Thomas SR, Bejan-Angoulvant T, Laugerotte A, Kahoul R, Gueyffier F (2011)
The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies, PLoS ONE, vol. 6(3) pp.1-7.

Mewton N, Revel D, Bonnefoy-Cudraz E, Ovize M, Croisille P (2011)
Comparison of visual scoring and quantitative planimetry methods for estimation of global infarct size on delayed enhanced cardiac MRI and validation with myocardial enzymes, European Journal of Radiology, vol. 78 pp.87-92.

Michallet M, Sobh M, Morisset S, Kraghel S, Nicolini F-E, Thomas X, Bienvenu A-L, Picot S, Nicolle M-C, Vanhems P (2011)
Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole, Medical Mycology October, vol. 49 pp.681-687.

Nicolle M-C, Bénet T, Thiebaut A, Bienvenu A-L, Voirin N, Duclos A, Sobh M, Cannas G, Thomas X, Nicolini F-E, De Monbrison F, Piens M-A, Picot S, Michallet M, Vanhems P (2011)
Invasive aspergillosis in patients with hematological malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009, Haematologica/The Hematology Journal, vol. 96 pp.1685-1691, DOI.

Peretti N, Loras-Duclaux I, Kassaï B, Restier-Miron L, Guimber D, Gottrand F, Coopman S, Michaud L, Marinier E, Yantren H, Michalski M-C, Aubert F, Mercier C, Pelosse M, Lopez M, Chatelain P, Lachaux A (2011)
Growth Hormone to Improve Short Bowel Syndrome Intestinal Autonomy : A Pediatric Randomized Open-Label Clinical Trial, Journal of Parenteral and Enteral Nutrition, vol. 20 pp.1-9.

Prandoni P, Casiglia E, Tikhonoff V, Leizorovicz A, Decousus H (2011)
The risk of subsequent cancer and arterial cardiovascular events in patients with superficial vein thrombosis in the legs, Blood, vol. 118 pp.775-784.

Quenet S, Laroche J-P, Bertoletti L, Quéré I, Décousus H, Becker F, Leizorovicz A (2011)
Value of a Planned Compression Ultrasonography after an Isolated Superficial Vein Thrombosis: Results from a Prospective Multicentre Study, European Journal of Vascular and Endovascular Surgery, vol. pp.1-5.

Sonié S, Kassaï B, Pirat E, Masson S, Bain P, Robinson J, Reboul A, Wicker B, Chevallier C, Beaude-Chervet V, Deleage M-H, Charvet D, Barthélémy C, Rochet T, Tatou M, Arnaud V, Manificat S (2011)
Version française des questionnaires de dépistage de l`autisme de haut niveau ou du syndrome d`Asperger chez l`adolescent : Quotient du spectre de l`autisme Quotient d`Empathie et Quotient de Systématisation. Protocole et traduction des questionnaires, La presse médicale, vol. pp.1-15.

Tod M, Goutelle S, Clavel-Grabit F, Nicolas G, Charpiat B (2011)
Quantitative prediction of cytochrome P450(CYP) 2D6-Mediated drug interactions, Clinical Pharmacokinetics, vol. 50(8) pp.519-530.

Tod M, Goutelle S, Gagnieu M C, Group The Genophar II Working (2011)
Genotype-Based Quantitative Prediction of Drug Exposure for Drugs Metabolized by CYP2D6, Clinical Pharmacology and Therapeutics, vol. 90 pp.582-587.

Villar E, Lièvre M, Kessler M, Lemaitre V, Alamartine E, Rodier M, François M, Zaoui P, Moranne O, Choukroun G, Guerraoui A, Jolivot A, Janin G, Branger B, Heng AE, Boudray C, Bissery A, Rabilloud M, Pouteil-Noble C (2011)
Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial, Journal of Diabetes and Its complications, vol. pp.1-7.

Wallon M, Kieffer F, Binquet C, Thulliez P, Garcia-Méric P, Dureau P, Franck J, Peyron F, Bonnin A, Villena I, Bonithon-Kopp C, Gouyon J-B, Masson S, Félin A, Cornu C (2011)
Toxoplasmose congénitale : comparaison randomisée de stratégies de prévention des rétinochoroïdites, Thérapie, vol. 66 pp.473-480.

Westerhout CM, Bonnefoy-Cudraz E, Welsh RC, Steg P-G, Boutitie F, Armstrong PW (2011)
The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST, American Heart Journal, vol. 161(2) pp.283-290.

Zegbeh H, Bleyzac N, Berhoune C, Bertrand Y (2011)
Vancomycine : quelles doses pour une meilleure efficacité en hémato-oncologie pédiatrique ?, Archives de Pédiatrie, vol. 18 pp.850-855, DOI.

Bejan-Angoulvant T (2010)
Analyse de la réduction du risque cardiovasculaire par le traitement antihypertenseur : vers une prescription personnalisée .

Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, Schron EB, Lindholm LH, Fagard R, Staessen JA, Gueyffier F (2010)
Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials, Journal of Hypertension, vol. 28 pp.1366-1372.

Belch JJF, Dormandy J, Caspar (2010)
Results of the randomized placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial, Journal of vascular surgery, vol. 52(4) pp.825-833.

Bodin J (2010)
Modélisation de la pharmacocinétique et des mécanismes d’action intracellulaire du 5-fluorouracile: Applications à l’étude de la variabilité de l’effet thérapeutique en population et à l’innovation thérapeutique .

Chapuisat G, Dronne MA, Grenier E, Hommel M, Boissel J-P (2010)
In Silico Study of the Influence of Intensity and Duration of Blood Flow Reduction on Cell Death Through Necrosis or Apoptosis During Acute Ischemic Stroke, Acta Biotheor, vol. 58 pp.171-190.

Cornu C, Joseph P, Gaillard S, Bauer C, Vedrinne C, Bissery A, Melot G, Bossard N, Belon P, Lehot J-J (2010)
No effect of a homoeopathic combination of Arnica montana and Bryonia alba on bleeding inflammation and ischaemia after aortic valve surgery, British Journal of Clinical Pharmacology, vol. 69(2) pp.136-142.

Cornu C, Remontet L, Noel-Baron F, Nicolas A, Feugier-Favier N, Roy P, Claustrat B, Saadatian-Elahi M, Kassaï B (2010)
A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial, BMC Complementary and alternative medicine, vol. 10(29) pp.1-32.

De Souza Neto EP, Grousson S, Duflo F, Gandreau S, ROusson D, Cornu C, Mottolese C, Froment JC, Dailler F (2010)
Conception et évaluation de la qualité d`une information écrite sur le scanner et l`imagerie par résonnace magnétique en neuropédiatrie, Annales Françaises d`Anesthésie et Réanimation, vol. 29 pp.704-709.

Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, Laporte S, Matyas L, Middeldorp S, Sokurenko G, Leizorovicz A (2010)
Fondaparinux for the Treatment of superficial-vein thrombosis in the legs, The new england journal o f medicine, vol. 363(13) pp.1222-1232.

Derex L, Bonnefoy-Cudraz E, Delahaye F (2010)
Impact of stroke on therapeutic decision making in infective endocarditis, J Neurol, vol. 257 pp.315-321.

Di Russo C, Lagaert J-B, Chapuisat G, Dronne MA (2010)
A mathematical model of inflammation during ischemic stroke, EDP sciences, vol. 30 pp.15-33.

Domenech C, Thomas X, Chabaud S, Baruchel A, Gueyffier F, Mazingue F, Auvrignon A, Corm S, Dombret H, Chevallier P, Galambrun C, Huguet F, Legrand F, Mechinaud F, Vey N, Philip I, Liens D, Godfrin Y, Rigal D, Bertrand Y (2010)
L-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial, British Journal of Haematology, vol. pp.1-8.

El Khoury C, Dubien P-Y, Mercier C, Belle L, Debaty G, Capel O, Perret T, Savary D, Serre P, Bonnefoy-Cudraz E, Mercier C, Bissery A, Ecochard R, Plattner V (2010)
Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study, Archives of cardiovascular diseases, vol. 103(5) pp.285-292.

Gerard C, Bleyzac N, Girard P, Freyer G, Bertrand Y, Tod M (2010)
Influence of dosing schedule on organ exposure to cyclosporin in pediatric hematopoietic stem cell transplantation: analysis with a PBPK model, Pharm Res, vol. 27 pp.2602-13, DOI.

Goutelle S, Larcher R, Padoin C, Mialou V, Bleyzac N (2010)
Oral Voriconazole Dose in children: One size does not fit all, Clinical Infectious Diseases, vol. 51 pp.870-870.

Grenier E, Bresch D, Dronne MA, Hommel M, Boissel JP (2010)
A phenomenological model of the growth of the necrotic area in ischemic stroke, Mathematical and Computer Modelling, vol. 51 pp.1011-1025, DOI.

Laforest L, Denis F, Van Ganse E, Ritleng C, Saussier C, Passante N, Devouassoux G, Chatte G, Freymond N, Pacheco Y (2010)
Correlates of adherence to respiratory drugs in COPD patients, Prim Care Respir J, vol. 19 pp.148-154, DOI.

Maucort-Boulch D, Baron M-H, Pommier P, Weber DC, Mizoe JE, Rochat J, Boissel J-P, Balosso J, Tsujii H, Amsallem E (2010)
Rationale for carbon ion therapy in high-grade glioma based on a review and ameta-analysis of neutron beam trials, Cancer Radiothérapie, vol. 14 pp.34-41, DOI.

Mewton N, Croisille P, Gahide G, Rioufol G, Bonnefoy-Cudraz E, Sanchez I, Cung T T, Sportouch C, Angoulvant D, Finet G, André-Fouët X, Derumeaux G, Piot C, Vernhet H, Revel D, Ovize M (2010)
Effect of Cyclosporine on Left Ventricular Remodeling After Reperfused Myocardial Infarction, Journal of the American College of Cardiology, vol. 55 pp.1200-205, DOI.

Nguyen K-A, Claris O, Kassaï B (2010)
Unlicensed and off-label drug use in a neonatal unit in France, Acta Paediatrica, vol. 100 pp.615-617, DOI.

Olli-Lahdesmaki T, Haataja L, Parkkola R, Waris M, Bleyzac N, Ruuskanen O (2010)
High-dose ganciclovir in HHV-6 encephalitis of an immunocompetent child, Pediatr Neurol, vol. 43 pp.53-6, DOI.

Ovize M, Bonnefoy-Cudraz E (2010)
Giving the ischaemic heart a shot in the arm, Lancet, vol. 27 pp.699-700.

Sermet C, Andrieu V, Godman B, Van Ganse E, Haycox A, Reynier JP (2010)
Ongoing Pharmaceutical Reforms in France, Appl Health Econ Health Policy, vol. 8 pp.7-24.

Stagnara J, Racle B, Vermont J, Kassaï B, Jacquel J, Duquesne A, Bourrillon A (2010)
Information et éducation des familles des enfants en situation d’urgence: diffusion téléphonique des messages, Archives de Pédiatrie, vol. 17 pp.854-855.

Stagnara J, Racle B, Vermont J, Kassaï B, Jacquel J, Duquesne A, Bourrillon A (2010)
Information et éducation des familles des enfants en situation d’urgence: méthodes d’élaboration des messages, Archives de Pédiatrie, vol. 17 pp.852-853.

Stagnara J, Racle B, Vermont J, Kassaï B, Jacquel J, Duquesne A, Bourrillon A (2010)
Information et éducation des familles des enfants en situation d’urgence: objectifs des messages de santé, Archives de Pédiatrie, vol. 17 pp.850-851.

Stagnara J, Racle B, Vermont J, Kassaï B, Jacquel J, Duquesne A, Bourrillon A (2010)
Information et éducation des familles des enfants en situation d`urgence: suivi d`intervention, Archives de Pédiatrie, vol. 17 pp.856-857.

Stagnara J, Vermont J, Jacquel J, Bagou G, Masson S, Kassaï B, Chatelain P (2010)
Réduction des consultations non programmées et non justifiées dans le cadre des urgences pédiatriques grâce à une plateforme téléphonique, La presse médicale, vol. 39(11) pp.e258-e263.

Walsh T, Goutelle S, Jelliffe R-W, Golden JA, Little EA, DeVoe C, Mickiene D, Hayes M, Conte JE (2010)
Intrapulmonary Pharmacokinetics and Pharmacodynamics of Micafungin in Adult Lung Transplant Patients, Antimicrobial agents and chemotherapy, vol. 54(8) pp.3451-3459.

Bacchetta J, Harambat J, Dubourg L, Guy B, Liutkus A, Canterino I, Kassaï B, Putet G, Cochat P (2009)
Both extrauterine and intrauterine growth restriction impair renal function in children born very preterm, Kidney International, vol. 76(4) pp.445-452.

Bajard A, Chabaud S, Pérol D, Boissel J-P, Nony P (2009)
Revisiting the level of evidence in randomized controlled clinical trials: A simulation approach, Contemporary Clinical Trials, vol. 30(5) pp.400-410.

Billy F (2009)
Modélisation mathématique multi-échelle de l`angiogenèse tumorale. Analyse de la réponse tumorale aux traitements anti-angiogéniques .

Billy F, Ribba B, Saut O, Morre-Trouilhet H, Colin T, Bresch D, Boissel J-P, Grenier E, Flandrois J-P (2009)
A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy, Journal of Theoretical Biology, vol. 260 pp.545-562.

Bonnefoy E, Steg P-G, Boutitie F, Dubien P-Y, Lapostolle F, Roncalli J, Dissait F, Vanzetto G, Leizorowicz A, Kirkorian G (2009)
Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up, European Heart Journal, vol. 30(13) pp.1598-1606, DOI.

Bonnefoy-Cudraz E, Steg P G, Boutitie F, Dubien P-Y, Lapostolle F, Roncalli J, Dissait F, Vanzetto G, Leizorowicz A, Kirkorian G (2009)
Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up, European Heart Journal, vol. 30 pp.1598-1606.

Bourguignon L, Goutelle S, Burdin de Saint Martin J, Guillermet A, Bouniot P, Maire P, Ducher M (2009)
Variabilité pharmacocinétique intra-individuelle et traitement antibiotique prolongé, Médecine et maladies infectieuses, vol. 2859 pp.1-4.

Bourguignon L, Goutelle S, Burdin de Saint Martin J, Maire P, Ducher M (2009)
Evaluation of various gentamicin dosage regimens in geriatric patients: a simulation study, Fundamental & Clinical Pharmacology, vol. pp.1-5.

Bourguignon L, Goutelle S, Gérard C, Guillermet A, Burdin de Saint Martin J, Maire P, Ducher M (2009)
Pharmacocinétique de l’amikacine chez l’adulte : une hétérogénéité qui remet en cause le calcul de la dose basé sur le poids, Thérapie, vol. 64(1) pp.1-5.

Bousquet PJ, Demoly P, Romano A, Aberer W, Bircher A, Blanca M, Brockow K, Pichler W, Torres MJ, Terreehorst I, Arnoux B, Atanaskovic-Markovic M, Barbaud A, Bijl A, Bonadonna P, Burney P G, Caimmi S, Canonica GW, Cernadas J, Dahlen B, Daures JP, Fernandez J, Gomes E, Gueant JL, Kowalski ML, Kvedariene V, Mertes PM, Martins P, Nizankowska-Mogilnicka E, Papadopoulos N, Ponvert C, Pirmohamed M, Ring J, Salapatas M, Sanz ML, Szczeklik A, Van Ganse E, De Weck AL, Zuberbier T, Merk HF, Sachs B, Sidoroff A (2009)
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project, Allergy, vol. 64 pp.194-203, DOI.

Cornu C, Bissery A, Malbos C, Garwig R, Cocherel C, Ecochard R, Peyron F, Wallon M (2009)
Factors affecting the adherence to an antenatal screening programme : an experience with toxopoplasmosis sreenning in France, Eurosurveillance Bulletin européen des maladies transmissibles, vol. 14(9) pp.21-25.

Cottraux J, Druon Note I, Boutitie F, Milliery M, Genouihlac V, Yao SN, Note B, Mollard E, Bonasse F, Gaillard S, Djamoussian D, C de Mey, Culem A, Gueyffier F (2009)
Cognitive Therapy versus Rogerian Supportive Therapy in Borderline Personality Disorder, Psychotherapy and psychosomatics, vol. 78(5) pp.307-316.

Debouverie M, Laforest L, Van Ganse E, Guillemin F (2009)
Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients, Mult Scler, vol. 15 pp.251-257, DOI.

Desamericq G, Revol A, Laforest L, Chamba G, Bauguil G, Ritleng C, Van Ganse E (2009)
Migraine or headache management: a pharmacy survey, Thérapie, vol. 64 pp.395-403, DOI.

Doreau A, Belot Al, Bastid J, Riche B, Trescol-Biemont M-C, Ranchin B, Fabien N, Cochat P, Pouteil-Noble C, Trolliet P, Durieu I, Tebib J, Kassaï B, Ansieau S, Puisieux A, Eliaou J-F, Bonnefoy-Bérard N (2009)
Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus, Nature Immunology, vol. 10(7) pp.778-788.

Dronne MA, Descombes S, Grenier E, Gilquin H (2009)
Examples of the influence of the geometry on the propagation of progressive waves, Mathematical and Computer Modelling, vol. 49(11-12) pp.2138-2144.

Garin O, Ferrer M, Pont A, Rue M, Kotzeva A, Wiklund I, Van Ganse E, Alonso J (2009)
Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses, Qual Life Res, vol. 18 pp.71-85, DOI.

Goutelle S, Bourguignon L, Bertrand-Passeron N, Jelliffe R-W, Maire P (2009)
Visual estimation of patients’ body weight in hospital: the more observers the better?, Pharmacy World & Science, vol. pp.1-4, DOI.

Goutelle S, Bourguignon L, Ducher M, Maire P (2009)
Modification of Diet in Renal Disease and Modified Cockcroft-Gault Formulas in Predicting Aminoglycoside Elimination, The Annals of Pharmacotherapy, vol. 43 pp.1143-1146.

Goutelle S, Bourguignon L, Maire P, Van Guilder M, Conte J-D, Jelliffe R-W (2009)
Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs, Antimicrobial agents and chemotherapy, vol. 53(7) pp.2974-2981, DOI.

Kassai B, Gueyffier F, Rabilloud M (2009)
Fondements de l`évaluation des tests diagnostiques, Lecture critique d`article, vol. 59 pp.375-379.

Laforest L, El Hasnaoui A, Pribil C, Ritleng C, Osman LM, Schwalm MS, Le Jeunne P, Van Ganse E (2009)
Asthma patients` self-reported behaviours toward inhaled corticosteroids, Respir Med, vol. 103 pp.1366-1375, DOI.

Laforest L, Souchet T, Moulin P, Ritleng C, Desamericq G, Le Jeunne P, Schwalm MS, Van Ganse E (2009)
Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs, Arch Cardiovasc Dis, vol. 102 pp.43-50, DOI.

Laforest L, Van Ganse E, Ritleng C, Desamericq G, Letrilliart L, Moreau A, Rosen S, Mechin H, Chamba G (2009)
Correlates of quality of life of pre-obese and obese patients: a pharmacy-based cross-sectional survey, BMC Public Health, vol. 9 pp.337-337, DOI.

Lelekov-Boissard T , Chapuisat G, Boissel J-P, Grenier E, Dronne MA (2009)
Exploration of beneficial and deleterious effects of inflammation in stroke: dynamics of inflammation cells, Philosophical Transactions of the Royal Society A-Mathematical Physical and engineering sciences, vol. 367 pp.4699-4716.

Loffroy R, Bernard S, Serusclat A, Boussel L, Bonnefoy-Cudraz E, D`Athis P, Moulin P, Revel D, Douek P (2009)
Noninvasive assessment of the prevalence and characteristics of coronary atherosclerotic plaques by multidetector computed tomography in asymptomatic type 2 diabetic patients at high risk of significant coronary artery disease: A preliminary study, Archives of Cardiovascular Disease, vol. 102 pp.607-615.

Marchant I, Boissel J-P, Kassaï B, Bejan-Angoulvant T, Massol J, Vidal C, Amsallem E, Naudin F, Galan P, Czernichow S, Nony P, Gueyffier F (2009)
SCORE should be preferred to Framingham to predict cardiovascular death in French population, European Journal of cardiovascular prevention & rehabilitation, vol. 16(5) pp.609-615.

Marec-Bérard P, Bissery A, Kebaïli K, Schell M, Aubert F, Gaillard S, Rabilloud M, Kassaï B, Cornu C (2009)
A positioning pillow to improve lumbar puncture success rate in paediatric haematology-oncology patients: a randomized controlled trial, BMC Cancer, vol. 9(21) pp.1-7, DOI.

Mewton N, Bonnefoy-Cudraz E, Revel D, Ovize M, Kirkorian G, Croisille P (2009)
Presence and Extent of Cardiac Magnetic Resonance Microvascular Obstruction in Reperfused Non-ST-Elevated Myocardial Infarction and Correlation with Infarct Size and Myocardial Enzyme Release, Cardiology, vol. 113 pp.50-58.

Mottard N, David J-S, Mewton N, Abdellaoui M, Cheron A, Macabeo C, Bonnefoy-Cudraz E, Piriou V (2009)
Infarctus du myocarde peropératoire quelle prise en charge à la phase aiguë ?, Annales françaises d`Anesthésie et de Réanimation, vol. 28 pp.692-969.

Planchamp F, Nguyen K-A, Vial T, Nasri S, Javouhey E, Gillet Y, Ranchin B, Villard F, Floret D, Cochat P, Gueyffier F, Kassaï B (2009)
Recueil systématique et actif des evènements indésirables médicamenteux chez les enfants admis aux urgences pédiatriques, Archives de Pédiatrie, vol. 16(2) pp.106-111.

Wang H, Boissel J-P, Nony P (2009)
Revisiting the relationship between baseline risk and risk under treatment, Emerging Themes in Epidemiology, vol. 6(1) pp.3451-3459, DOI.

Bacchetta J, Cochat P, Villard F, Astier M, Vial T, Dubourg L, Hadj-Aissa A, Kassaï B (2008)
Hypersensitivity to inulin : a rare and mostly benign event, American Journal of Kidney Diseases, vol. 52(3) pp.632-633.

Bacchetta J, Villard F, Vial T, Dubourg L, Bouvier R, Kassaï B, Cochat P (2008)
‘Renal hypersensitivity’ to inulin and IgA nephropathy, Pediatric Nephrology, vol. 23(10) pp.1883-1885, DOI.

Bejan-Angoulvant T, Bouvier A-M, Bossard N, Belot A, Jooste V, Launoy G, Remontet L (2008)
Hazard regression model and cure rate model in colon cancer relative survival trends: are they telling the same story?, European Journal of Epidemiology, vol. 23 pp.251-259.

Bleyzac N (2008)
The use of pharmacokinetic models in paediatric onco-haematology: effects on clinical outcome through the examples of busulfan and cyclosporine, Fundamental & Clinical Pharmacology, vol. 22(6) pp.605-608.

Boissel J-P, Cucherat M, Nonyc P, Chabaud S, Gueyffier F, Wright JM, Lièvre M, Leizorovicz A (2008)
New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linear, Journal of Clinical Epidemiology, vol. 61(3) pp.301-307, DOI.

Boissel J-P, Ribba B , Grenier E, Chapuisat G, Dronne MA (2008)
Modelling methodology in physiopathology, Progress in Biophysics & Molecular Biology, vol. 97 pp.28-39.

Bourguignon L, Goutelle S, Bouniot P, Guillermet A, Burdin de Saint-Martin J, Maire P, Ducher M (2008)
Pharmacocinétique de la teicoplanine chez le sujet âgé : construction d’un modèle pour le suivi thérapeutique, Journal de Pharmacie Clinique, vol. 27 n°3 pp.189-194.

Boussageon R, Gueyffier F, Bejan-Angoulvant T, Felden-Dominiak G (2008)
Critique du modèle additif de l`essai clinique randomisé, Thérapie, vol. 63(1) pp.29-35.

Chapuisat G, Dronne MA, Grenier E, Hommel M, Gilquin H, Boissel J-P (2008)
A global phenomenological model of ischemic stroke with stress on spreading depressions, Progress in Biophysics & Molecular Biology, vol. 97 pp.4-27.

Danchin N, Coste P, Ferrières J, Steg P-G, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, Sans P, Charbonnier B, Eltchaninoff H, Guéret P, Khalife K, Asseman P, Puel J, Goldstein P, Cambou J-P, Tabassome S (2008)
Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Acute Myocardial Infarction, Circulation, vol. 118 pp.268-276, DOI.

Devouassoux G, Pachot A, Laforest L, Diasparra J, Freymond N, Van Ganse E, Mougin B, Pacheco Y (2008)
Galectin-10 mRNA is overexpressed in peripheral blood of aspirin-induced asthma, Allergy, vol. 63 pp.125-131, DOI.

Dronne MA, Grenier E , Chapuisat G, Hommel M, Boissel J-P (2008)
A modelling approach to explore some hypotheses of the failure of neuroprotective trials in ischemic stroke patients, Progress in Biophysics & Molecular Biology, vol. 97 pp.60-78.

El-Cheikh J, Michallet M, Nagler A, de Lavallade H , Nicolini FE, Shimoni A, Faucher C, Sobh M, Revesz D, Hardan I, Fürst S, Blaise D, Mohty M (2008)
High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma, Haematologica-The Hematology Journal, vol. 93 pp.455-458.

Goutelle S, Maurinc M, Rougier F, Barbaut X, Bourguignon L, Ducher M, Maire P (2008)
The Hill equation: a review of its capabilities in pharmacological modelling, Fundamental & Clinical Pharmacology, vol. 22 pp.633-648, DOI.

Grenier E, Dronne MA, Descombes S , Gilquin H, Jaillard A, Hommel M, Boissel J-P (2008)
A numerical study of the blocking of migraine by Rolando sulcus, Progress in Biophysics & Molecular Biology, vol. 97(1) pp.54-89.

Kassaï B, Bacchetta J (2008)
Comment lire un article rapportant un test diagnostique?, Médecine, vol. 1 pp.1-3.

Kassaï B, Cucherat M, Bellon G (2008)
Ciclesonide noninferiority to placebo on growth velocity, Pediatrics, vol. 122 pp.676-677.

Kitio B, Bertholle V, Galambrun C, Mialou V, Bertrand Y, Aulagner G, Bleyzac N (2008)
Risk-adjusted monitoring of veno-occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics, Pharmacoepidemiol Drug Saf, vol. 17 pp.135-43, DOI.

Laforest L, Com-Ruelle L, Devouassoux G, Pison C, Van Ganse E (2008)
Economic aspects of severe asthma, Presse Med, vol. 37 pp.117-28, DOI.

Laforest L, Moulin P, Souchet T, Ritleng C, Desamericq G, Le Jeunne P, Schwalm MS, Kieffer A, Van Ganse E (2008)
Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy, Atherosclerosis, vol. 199 pp.368-377, DOI.

Laforest L, Van Ganse E, Devouassoux G, El Hasnaoui A, Osman L M, Bauguil G, Chamba G (2008)
Dispensing of antibiotics antitussives and mucolytics to asthma patients: a pharmacy-based observational survey, Respir Med, vol. 102 pp.57-63, DOI.

Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung T, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, André-Fouet X, Revel D, Kirkorian G, Monassier J-P, Derumeaux g, Ovize M (2008)
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction, New England Journal of Medicine, vol. 359(5) pp.473-481.

Riley RD, Lambert PC, Staessen JA, Wang J, Gueyffier F, Thijs L, Boutitie F (2008)
Meta-analysis of continuous outcomes combining individual patient data and aggregate data, Statistics in Medicine, vol. 27(11) pp.1870-1893.

Sobh M, Cleophas TJ, Hadj-Chaib A, Zwinderman AH (2008)
Clinical Trials: Odds Ratios and Multiple Regression Models—Why and How to Assess Them, American Journal of Therapeutics, vol. 15 pp.44-52.

Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung T, Bonnefoy E, Angoulvant D, Aupetit J-F, Finet G, André-Fouët X, Macia J-C, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M (2008)
Long-Term Benefit of Postconditioning, Circulation, vol. 117 pp.1037-1044, DOI.

Valla F, Leveque N, Escuret V, Galambrun C, Mialou V, Bleyzac N, Bertrand Y (2008)
Human cytomegalovirus (HCMV) laryngitis: atypical HCMV disease presentation in haematopoietic stem cell transplantation, J Med Microbiol, vol. 57 pp.1434-5, DOI.

Amsallem E, Kasparian C, Cucherat M, Chabaud S, Haugh MC, Boissel J-P, Nony P (2007)
Evaluation of two evidence-based knowledge transfer interventions for physicians. A cluster randomized controlled factorial design trial: the CardioDAS study, Fundamental & Clinical Pharmacology, vol. 21 pp.631-641.

Boussageon R, Gueyffier F, Moreau A, Gansel Y, Boussageon V (2007)
Some reflexions about double blind, Encephale-Revue de Psychiatrie clinique biologique et therapeutique, vol. 34(4) pp.347-351, DOI.

Boutitie F, Gueyffier F, Achard JM (2007)
The JIKEI trial, Lancet, vol. 370 pp.1825-1826.

Boutitie F, Oprisiu R, Achard JM, Mazouz H, Wang J, Messerli FH, Gueyffier F, Fournier A (2007)
Does a change in angiotensin-II-formation caused by antihypertensive drugs affect the risk of stroke ? A meta-analysis of trials according to treatment with potentially different effects on angiotensin-II, Journal of Hypertension, vol. 25 pp.1543-1553.

Cleophas TJ, Zwinderman AH, van Ouwerkerk B, Sobh M (2007)
Cardiovascular drug trials: how to examine interaction and why so, Netherlands heart journal, vol. 15 pp.61-66.

Dronne MA, Grenier E, Dumont T, Hommel M, Boissel J-P (2007)
Role of astrocytes in grey matter during stroke: a modelling approach, Brain Research, vol. 1138 pp.231-242.

Gellis C, Sautou-Miranda V, Bleyzac N, Jarrige J-F, Minet-Quinard R, Chopineau J (2007)
Continuous infusion of methylprednisolone viapaediatric parenteral nutrition: A pharmacokinetic animal study, Clinical Nutrition, vol. 26 pp.491-497.

Gueyffier F, Bejan-Angoulvant T (2007)
Do We Need to Assess the Effect of Treatment Withdrawal? The Paradigm of Life-Long Prevention, Journal of the American Hearth Association, vol. pp.219-226, DOI.

Jacqz-Aigraina E, Kassaï B (2007)
Presentation of the French Network of Paediatric Clinical Investigation Centres (CIC.P), Fundamental & Clinical Pharmacology, vol. 21 pp.105-110.

Kassaï B, Bacchetta J (2007)
Effets indésirables à long terme des médicaments: comment améliorer la prise en charge?, Archives de Pédiatrie, vol. 14(6) pp.603-604.

Kassaï B, Chiron C, Augier S, Cucherat M, Rey E, Gueyffier F, Guerrini R, Vincent J, Dulac O, Pons G (2007)
Severe myoclonic epilepsy in infancy: A systematic review and a meta-analysis of individual patient data, Epilepsia, vol. 48 pp.1-6.

Kassaï B, Gueyffier F, Boissel J-P (2007)
Critères intermédiaires et critères de substitution, Médecine thérapeutique, vol. 13(4) pp.279-286.

Laforest L, Moulin P, Schwalm M , Le Jeunne P, Chretin S, Kitio B, Massol J, Van Ganse E (2007)
Use of margarine enriched in phytosterols by patients at high cardiovascular risk and treated by hypolipidemic drugs, Nutr Metab Cardiovasc Dis, vol. 17 pp.657-665, DOI.

Laforest L, Van Ganse E, Devouassoux G, Osman LM, Bauguil G, Chamba G (2007)
Patient-reported Adverse Events Under Asthma Therapy: A Community Pharmacy-based Survey, Clinical Pharmacology and Therapeutics, vol. 82 pp.167-172, DOI.

Laforest L, Van Ganse E, Devouassoux G, Osman LM, Brice K, Massol J, Bauguil G, Chamba G (2007)
Asthmatic patients` poor awareness of inadequate disease control: a pharmacy-based survey, ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, vol. 98 pp.146-152.

Leizorovicz A (2007)
Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography study, Haematologica-The Hematology Journal, vol. 92(9) pp.1194-1200, DOI.

Mercier C, Boissel J-P, Estève J, Iwaz J, Nony P (2007)
New tools to measure discrepancy between prescribing practices and guideline recommendations, Journal of Evaluation In Clinical Practice, vol. 13 pp.639-646.

Normand P, Lapierre P, Tisa LS, Gogarten JP, Alloisio N, Bagnarol E, Bassi CA, Berry AM, Bickhart DM, Choisne N, Couloux A, Cournoyer B, Cruveiller S, Daubin V, Demange N, Francino MP, Goltsman E, Huang Y, Kopp OR, Labarre L, Lapidus A, Lavire C, Marechal J, Martinez M, Mastronunzio JE, Mullin BC, Niemann J, Pujic P, Rawnsley T, Rouy Z, Schenowitz C, Sellstedt A, Tavares F, Tomkins JP, Vallenet D, Valverde C, Wall LG, Wang Y, Medigue C, Benson DR (2007)
Genome characteristics of facultatively symbiotic Frankia sp. strains reflect host range and host plant biogeography, Genome Research, vol. pp.7-15.

Roussel R, Mentre F, Bouchemal N, Hadjadj S, Lièvre M, Chatellier G, Menard J, Panhard X, Le Henanff A, Marre M, Le Moyec L (2007)
NMR-based prediction of cardiovascular risk in diabetes, Nature Medicine, vol. 13 pp.399-400.

Roze S, Ferrieres J, Bruckert E, Van Ganse E, Chapman MJ, Liens D, Renaudin C (2007)
Cost-effectiveness of raising HDL cholesterol by adding prolonged-release nicotinic acid to statin therapy in the secondary prevention setting: a French perspective, Int J Clin Pract, vol. 61 pp.1805-1811, DOI.

Skilton MR, Moulin P, Sérusclat A, Nony P, Bonnet F (2007)
A comparison of the NCEP-ATPIII IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: Evidence for sex-specific differences, Atherosclerosis, vol. 190 pp.416-422.

Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T (2007)
Mixed Dyslipidemia Among Patients Using Lipid-Lowering Therapy in French General Practice: An Observational Study, Clinical Therapeutics, vol. 29 pp.1671-1681, DOI.

Atoui H, Fayn J, Gueyffier F, Rubel P (2006)
Cardiovascular Risk Stratification in Decision Support Systems: A Probabilistic Approach. Application to pHealth, Computers in Cardiology, vol. 33 pp.281-284.

Azizi M, Menard J, Peyrard S, Lièvre M, Marre M, Chatellier G (2006)
Assessment of Patients` and Physicians` Compliance to an ACE Inhibitor Treatment Based on Urinary N-Acetyl Ser-Asp-Lys-Pro Determination in the Noninsulin-Dependent Diabetes Hypertension Microalbuminuria Proteinuria Cardiovascular Events and Ramipril (DIABHYCAR) Study, Diabetes Care, vol. 29 pp.1331-1336.

Blesius A, Chabaud S, Cucherat M, Mismetti P, Boissel J-P, Nony P (2006)
Compliance-Guided Therapy: A New Insight Into the Potential Role of Clinical Pharmacologists, Clinical Pharmacokinetics, vol. 45 pp.95-104.

Boissel J-P, Pouchain D, Brodin M, Rouleau P, Barrier G, Fardeau M, Rabeharisoa V, Cathelineau G, Bricaire F, Zarifian E (2006)
Définition du panier de soins remboursables (PSR) : propositions et schéma d`applications à la prévention, Revue médicale de l`assurance maladie, vol. 37 pp.125-131.

Brunet AS, Ploton C, Galambrun C, Pondarré C, Pages MP, Bleyzac N, Freydiere A-M, Barbé G, Bertrand Y (2006)
Low Incidence of Sepsis Due to Viridans Streptococci in a Ten-Year Retrospective Study of Pediatric Acute Myeloid Leukemia, Pediatric Blood & Cancer, vol. 47(6) pp.765-772.

Dronne MA, Boissel J-P, Grenier E (2006)
A mathematical model of ion movements in grey matter during a stroke, Journal of Theoretical Biology, vol. 240 pp.599-615.

Duflo F, Sautou-Miranda V, Pouyau A, Taylor P, Combet S, Chotel F, Bleyzac N, Chassard C (2006)
Efficacy and plasma levels of ropivacaine for children: controlled regional analgesia following lower limb surgery, British Journal of Anaesthesia, vol. 97(2) pp.250-254.

Duménil-Janoly A, Galambrun C, Basset T, Mialou V, Bertrand Y, Bleyzac N (2006)
Human herpes virus-6 encephalitis in a paediatric bone marrow recipient: successful treatment with pharmacokinetic monitoringand high doses of ganciclovir, Bone Marrow Transplantation, vol. 00 pp.1-2.

Dupuis O, Moreau R, Silveira R, Pham MT, Zentner A , Cucherat M, Rudigoz R-C, Redarce T (2006)
A new obstetric forceps for the training of junior doctors: A comparison of the spatial dispersion of forceps blade trajectories between junior and senior obstetricians, American Journal of Obstetrics and Gynecology, vol. 194 pp.1524-1531.

Fantino B, Voirin N, Laforest L , Fantino F, Chretin S, Van Ganse E (2006)
Primary care physicians` behaviors towards risk of iatrogenesis in elderly patients, European Journal of Clinical Pharmacology, vol. 62 pp.563-570.

Ferrières J, Cambou J-P, Gayet J-L, Herrmann M-A, Leizorovicz A (2006)
Prognosis of patients with atherothrombotic disease: A prospective survey in a non-hospital setting, International Journal of Cardiology, vol. 112(3) pp.302-307.

Fischer C, Luaute J, Nemoz C, Morlet D, Kirkorian G, Mauguiere F (2006)
Editorial response: Evoked potentials can be used as a prognosis factor for awakening, Critical Care Medicine, vol. 34 pp.2025-2025.

Fischer C, Luaute J, Nemoz C, Morlet D, Kirkorian G , Mauguiere F (2006)
Improved prediction of awakening or nonawakening from severe anoxic coma using tree-based classification analysis, Critical Care Medicine, vol. 34 pp.1520-1524.

Fouque D, Laville M, Boissel J-P (2006)
Low protein diets for chronic kidney disease in non diabetic adults, Cochrane Database of Systematic Reviews, vol. CD001892 pp.37-46.

Gueyffier F, Wright JM (2006)
Estimation of attributable burden of disease: authors’ reply, Journal of Hypertension, vol. 24(5) pp.171-175.

Gueyffier F, Wright JM (2006)
The lower the better: Does simplicity lead to absurdity?, Editorial comment, vol. 24(3) pp.431-433.

Kassaï B, Soniéb S, Shah NR, Boissel J-P (2006)
Literature search parameters marginally improved the pooled estimate accuracy for ultrasound in detecting deep venous thrombosis, Journal of Clinical Epidemiology, vol. 59 pp.710-714.

Kassaï B, Treluyer JM, Jacqz-Aigrain E, Pons G (2006)
La mise en place en Europe des réseaux d`investigation des médicaments chez l`enfant, Archives de Pédiatrie, vol. 13 pp.631-634.

Levêque N, Galambrun C, Najioullah F, Bleyzac N, Pages MP, Bertrand Y (2006)
Two Cases of Varicella Zoster Virus Meningitis Found in Pediatric Patients After Bone Marrow Transplantation Despite Valaciclovir Prophylaxis and Without Skin Lesions, Journal of Medical Virology, vol. 78(4) pp.514-516.

Liard F, Le Heuzey JY, Jaillon P, Lièvre M, Danchin N (2006)
Flecainide acetate utilisation review among general practitioners and hospital or office-based cardiologists in France. Obepine: observational study of flecainide, Annales de cardiologie et d`angéiologie, vol. 55 pp.113-122.

Lièvre M (2006)
Evaluation of adverse treatment effects in controlled trials, Joint Bone Spine, vol. 73 pp.624-626.

Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lièvre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touze E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X (2006)
Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis, New England Journal of Medicine, vol. 355 pp.1660-1671.

Monneret G, Lepape A, Voirin N, Bohé J, Venet F, Debard A-L, Thizy H, Bienvenu J, Gueyffier F, Vanhems P (2006)
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock, Intensive Care Medicine, vol. 32 pp.1175-1183.

Nguyen K-A, Vial T, Gueyffier F, Marignier S, Cochat P, Kassaï B (2006)
Safety of computerized drug management: a case report, British Journal of Clinical Pharmacology, vol. 63 pp.245-246.

Ribba B, Saut O, Colin T, Bresch D, Grenier E, Boissel J-P (2006)
A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents, Journal of Theoretical Biology, vol. 243 pp.532-541.

Ribba B, Tracqui P, Boix J-L, Boissel J-P, Thomas SR (2006)
QxDB: A generic database to support mathematical modeling in biology, Philosophical Transactions of Royal Society Series A on `Biomathematical Modelling`, vol. 364 pp.1517-1532.

Zannad F, Kessler M, Lehert P, Grünfeld JP, Thuilliez C, Leizorovicz A, Lechat P (2006)
Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies, Kidney International, vol. 70(7) pp.1318-1334.

Amsallem E, Kasparian C, Haddour G, Boissel J-P, Nony P (2005)
Phosphodiesterase III inhibitors for heart failure, Cochrane Database of Systematic Reviews, vol. CD002230 pp.631-641.

Barna A, Baudet M, Cambou J-P, Chatellier G, Cucherat M, Dallongeville J, Durlach V, Giral P, Gueyffier F, Kownator S, Lang T, Léonard D, Pace E, Paillard F, Vallée J-P, Vergès B, Aquino J-P , Aulanier S, Balarac N, Beucler I, Bobrie G, Caporossi L, Dénolle T, D`Ivernois C, Dumarcet N, Erpeldinger S, Farnier M, Ferrières J, Fischer C, Friocourt P, Girerd X, Godin M, Halimi S, Jean T, Lièvre M, Loirat P, Lucas C, Marechaud R, Marre M, Ménard J, Mimran A, Moulin P, Picard S, Poncelet P, Pouchain D, Scarabin P-Y, Seux M-L, Senechal M, Sicard D, Turpin G, Vaisse B, Vallée J (2005)
Methods for evaluation of total cardiovascular risk, Médecine thérapeutique, vol. 11 pp.233-236.

Boissel J-P, Cucherat M, Nony P , Dronne MA, Kassaï B, Chabaud S (2005)
Modélisation numérique et simulation : nouvelles applications en pharmacologie, Thérapie, vol. 60 pp.1-15.

Boissel J-P, Gueyffier F, Boutitie F, Pocock S, Fagard R (2005)
Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments, Fundamental & Clinical Pharmacology, vol. 19 pp.579-584.

Boissel J-P, Nony P, Amsallem E, Mercier C, Estève J, Cucherat M (2005)
How to measure non-consistency of medical practices with available evidence in therapeutics: a methodological framework, Fundamental & Clinical Pharmacology, vol. 19 pp.591-596.

Bonnefoy E, Godon P, Kirkorian G, Chabaud S, Touboul P (2005)
Significance of serum troponin I elevation in patients with acute aortic dissection of the ascending aorta, Acta Oecologia, vol. 60(2) pp.165-170.

Bonnefoy E, Steg P-G, Chabaud S, Dubien P-Y, Lapostolle F, Boudet F, Lacroute J-M, Dissait F, Vanzetto G, Leizorovicz A, Touboul P (2005)
Is primary angioplasty more effective than pre-hospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial., European Heart Journal, vol. 26 pp.1712-1718.

Bonnet F, Irving K, Terra JL, Nony P, Berthezène F, Moulin P (2005)
Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease, Atherosclerosis, vol. 178 pp.339-344.

Bonnet F, Irving K, Terra JL, Nony P, Berthezène F, Moulin P (2005)
Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome, Journal of Hypertension, vol. 23 pp.611-617.

Burri H, Chevalier P, Arzi M, Rubel P, Kirkorian G, Touboul P (2005)
Wavelet transform for analysis of heart rate variability preceding ventricular arrhythmias in patients with ischemic heart disease, International Journal of Cardiology, vol. 109 pp.101-107.

Kassaï B, Boissel J-P, Cucherat M, Boutitie F, Gueyffier F (2005)
Treatment of high blood pressure and gain in event-free life expectancy, Vascular health and risk management, vol. 1 pp.163-169.

Kassaï B, Shah NR, Leizorovicz A, Cucherat M, Gueyffier F, Boissel J-P (2005)
The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests, Journal of Clinical Epidemiology, vol. 58 pp.1042-1051.

Kirkorian G (2005)
Cardiac-Resynchronization Therapy in Heart Failure, New England Journal of Medicine, vol. 353;2 pp.245-261.

Kucher N, Leizorovicz A, Vaitkus PT, Cohen AT, Turpie AGG, Olsson C-G, Goldhaber SZ (2005)
Efficacy and Safety of Fixed Low-Dose Dalteparin in Preventing Venous Thromboembolism Among Obese or Elderly Hospitalized Patients, Archive of Internal Medicine, vol. 165 pp.341-345.

Lièvre M, Abadie E (2005)
Discontinuation of Vioxx, Lancet, vol. 365 pp.23-24.

Lièvre M, Marre M, Robert JJ, Charpentier G, Iannascoli F, Passa P (2005)
Cross-sectional study of care socio-economic status and complications in young French patients with type 1 diabetes mellitus, Diabetes and Metabolism, vol. 31 pp.41-46.

Stagnara J, Vermont J, Dürr F, Ferradji K, Mege L, Duquesne A, Ferley J-P, Kassaï B (2005)
L`attitude des parents face à la fièvre de leurs enfants, Press Med, vol. 34 pp.1129-1136.

Wang J-G, Staessen JA, Franklin S, Fagard R, Gueyffier F (2005)
Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome, Hypertension, vol. 45(5) pp.907-913, DOI.

Argaud L, Rioufol G, Lièvre M, Bontemps L, Legalery P, Stumpf M, Finet G, Itti R, Andre-Fouet X, Ovize M (2004)
Preconditioning during coronary angioplasty: no influence of collateral perfusion or the size of the area at risk, European Heart Journal, vol. 25 pp.2019-2025.

Bossard N, Boissel FH, Boissel J-P (2004)
Level of evidence and therapeutic evaluation: need for more thoughts, Fundamental & Clinical Pharmacology, vol. 18 pp.365-372.

Cornu C (2004)
Compte rendu de l’atelier « Phase I et phases précoces » Proceedings of the Workshop Entitled “Phase I and Early Phases”, Therapie, vol. 59 pp.145-6.

Dronne MA, Boissel J-P , Grenier E , Gilquin H, Cucherat M, Hommel M, Barbier E, Bricca G (2004)
Mathematical modelling of an ischemic stroke: An integrative approach, Acta Biotheoretica, vol. 52 pp.255-272.

Kassaï B, Boissel J-P, Cucherat M, Sonie S, Shah NR , Leizorovicz A (2004)
A systematic review of the accuracy of ultrasound in the diagnosis of deep venous thrombosis in asymptomatic patients, Thrombosis and Haemostasis, vol. 91 pp.655-666.

Lievre M (2004)
Type 2 diabetes and cardiovascular risk: Lessons from therapeutic trials, Médecine thérapeutique, vol. 10 pp.304-315.

Marre M, Lièvre M, Chatellier G (2004)
Trial finds low dose ramipril does not reduce cardiovascular or renal events in people with type 2 diabetes and albuminuria, Evidence-based cardiovascular medicine, vol. 8 pp.273-274.

Marre M, Lièvre M, Chatellier G, Mann JFE, Passa P, Menard J (2004)
Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised double blind placebo controlled trial (the DIABHYCAR study), British Medical Journal, vol. 328 pp.495-499.

Mas JL, Chatellier G, Beyssen B, Branchereau A, Becquemin JP, Bonneville JF, Crochet D, Gauz JC, Larrue V, Leys D, Watelet J, Hommel M, Magne JL, Mounier-Vehier F, Boyer L, Favre JP, Giroud M, Hassen-Kodja K, Ricco JB, Pruvo JP, Meder JF, Arquizan C, Becker F, Cattin F, Debray JM, Jausseran JM, Long A, Touboul PJ, Lièvre M, Beregi JP, Bogousslavsky J, Testart M (2004)
Carotid angioplasty and stenting with and without cerebral protection - Clinical alert from the Endarterectomy versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial, Stroke, vol. 35 pp.E18-E20.

Robert R, Rioufol G, Finet G, Cottin Y, Tabib A, Zeller M, Wolf JE, Lièvre M, Bricca G (2004)
Experimental assessment of new stent technologies: validation of a comparative paired rabbit iliac artery study model, Journal of Biomedical Materials Research, vol. 70B pp.303-310.

Rougier F, Claude D, Maurin M, Maire P (2004)
Aminoglycoside nephrotoxicity, Current Drug Targets - Infectious Disorders, vol. 4 pp.153-162.

Urien S, Laurent N , Barre J, Druguet M, D`yvoire MB , Maire P (2004)
Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime - a population study in 25 elderly patients, European Journal of Clinical Pharmacology, vol. 60 pp.11-16.

Uzzan B, Nicolas P, Cucherat M, Perret GY (2004)
Microvessel density as a prognostic factor in women with breast cancer: A systematic review of the literature and meta-analysis, Cancer Research, vol. 64 pp.2941-2955.

Yzèbe D, Lièvre M (2004)
Fish oils in the care of coronary heart disease patients: a meta-analysis of randomized controlled trials, Fundamental & Clinical Pharmacology, vol. 18(5) pp.581-592.

Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A (2003)
Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study, Journal of Vasculaire Surgery, vol. 37 pp.487-494.

Boissel J-P, Gueyffier F, Cucherat M, Bricca G (2003)
Pharmacogenetics and responders to a therapy: Theoretical background and practical problems, Clinical Chemistry and Laboratory Medicine, vol. 41 pp.564-572.

Boissel J-P, Haugh M, Fardeheb M, Nony P, Gueyffier F, Strang N (2003)
How should therapeutic information be transferred to users?, Fundamental & Clinical Pharmacology, vol. 17 pp.495-503.

Bonnefoy M, Cornu C, Normand S, Boutitie F, Bugnard F, Rahmani A, Lacour JR, Laville M (2003)
The effects of exercise and protein-energy supplements on body composition and muscle function in frail elderly individuals: a long-term controlled randomised study, British Journal of Nutrition, vol. 89 pp.731-739.

Bruckert E, Lièvre M, Giral P, Crepaldi G, Masana L, Vrolix M, Leitersdorf E, Dejager S (2003)
Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients, The American Journal of Geriatric Cardiology, vol. 12 pp.225-233.

Chevalier P, Burri H, Adeleine P, Kirkorian G, Lopez M, Leizorovicz A, Andre-Fouet X, Chapon P, Rubel P, Touboul P (2003)
QT dynamicity and sudden death after myocardial infarction: Results of a long-term follow-up study, Journal of Cardiovascular Electrophysiology, vol. 14 pp.227-233.

Chevalier P, Durand-Dubief A, Burri H, Cucherat M, Kirkorian G , Touboul P (2003)
Amiodarone versus placebo and classic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis, Journal of the American College of Cardiology, vol. 41 pp.255-262.

Clanet M, Cucherat M (2003)
Interferons in Relapsing-remitting MS: A systematic Review - Comments on a Meta-analysis, The International MS Journal, vol. 10 pp.134-135.

Cornu C , Carré C, Guetemme G, Ravis B, Thérond S, Gueyffier F, Bonnefoy M (2003)
Prévention de la dépendance des personnes âgées : étude randomisée dans la communauté Prevention of Dependency in Elderly Persons: A Randomised Study in the Community, Thérapie, vol. 89 pp.731-9.

Cucherat M (2003)
Lecture critique : un outil pragmatique, La revue du praticien - médecine générale, vol. 17 pp.752-754.

Cucherat M, Bonnefoy E, Tremeau G (2003)
Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction, , vol. 3 pp.752-754.

Cucherat M, Leizorovicz A (2003)
La méta-analyse des essais thérapeutiques. Concepts et interprétation des résultats, MT Thérapeutique, vol. 9 pp.73-78.

Ducher M, Fauvel JP, Maurin M, Laville M, Maire P, Paultre CZ , Cerutti C (2003)
Sodium intake and blood pressure in healthy individuals, Journal of Hypertension, vol. 21 pp.289-294.

Gueyffier F, Cucherat M (2003)
"Causality and statistical association (2) Mechanical determinism and stochastic model", La Revue du praticien, vol. 53 pp.933-936.

Hadjadj S, Gallois Y, Alhenc-Gelas F, Chatellier G, Marre M, Genes N, Lièvre M, Mann J, Menard J, Vasmant D (2003)
Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients, Diabetic Medicine, vol. 20 pp.677-682.

Janoly-Dumenil A, Bleyzac N, Richard I, Bourgeois J, Constant H, Putet G, Maire P, Aulagner G (2003)
Intérêt de l`individualisation des posologies de vancomycine par une méthode bayésienne dans un service de réanimation néonatale, Journal de pharmacie clinique, vol. 22 pp.95-100.

Kassaï B, Gueyffier F, Boissel J-P, Boutitie F, Cucherat M (2003)
Absolute benefit number needed to treat and gain in life expectancy: which efficacy indices for measuring the treatment benefit?, Journal of Clinical Epidemiology, vol. 56 pp.977-982.

Leizorovicz A, Kassaï B, Becker F, Cucherat M (2003)
The assessment of deep vein thromboses for therapeutic trials, Angiology, vol. 54 pp.19-24.

Lièvre M (2003)
Les biais en recherche clinique, Revue du Praticien, vol. 53 pp.2096-2098.

Martin P, Bleyzac N, Souillet G, Galambrun C, Bertrand Y , Maire P, Jelliffe RW, Aulagner G (2003)
Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors, Bone Marrow Transplantation, vol. 32 pp.881-887.

Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY (2003)
Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis - A comprehensive meta-analysis, Archives of Internal Medicine, vol. 163 pp.1514-1522.

Rougier F, Claude D, Maurin M, Sedoglavic A, Ducher M, Corvaisier S, Jelliffe R, Maire P (2003)
Aminoglycoside nephrotoxicity: modeling simulation and control, Antimicrobial Agents and Chemotherapy, vol. 47 pp.1010-1016.

Rougier F, Corvaisier S, Ducher M, Claude D, Jelliffe R W, Maire P (2003)
[PK/PD modeling of aminoglycoside nephrotoxicity], Pathologie Biologie (Paris), vol. 51 pp.234-236.

Rougier F, Ducher M , Maurin M , Corvaisier S, Claude D, Jelliffe R, Maire P (2003)
Aminoglycoside dosages and nephrotoxicity - Quantitative relationships, Clinical Pharmacokinetics, vol. 42 pp.493-500.

Vaur L, Gueret P, Lièvre M, Passa P (2003)
Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: lessons from the Diabhycar study, Diabetes Care, vol. 26 pp.855-860.

Villar E, Lièvre M, Labeeuw M, Pouteil-Noble C (2003)
Protocole de l’étude NEPHRODIAB2, Néphrologie, vol. 24(6) pp.317-319.

Foltz F, Ducher M, Rougier F, Coudray S, Bourhis Y, Druguet M, Maire P (2002)
Efficacy and toxicity of aminoglycoside therapy in the elderly: combined effect of both once-daily regimen and therapeutic drug monitoring, Pathologie Biologie (Paris), vol. 50 pp.227-232.

Fournier-Chambrillon C, Fournier P, Gaillard J-M, Genty C, Hansen E, Vie J C (2000)
Mammal trap efficiency during the fragmentation by flooding of a neotropical rain forest in French Guiana., Journal of Tropical Ecology, vol. 16 pp.841-851.